From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
Open Access
- 29 January 2008
- journal article
- case report
- Published by Springer Science and Business Media LLC in Malaria Journal
- Vol. 7 (1), 25
- https://doi.org/10.1186/1475-2875-7-25
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The challenges of changing national malaria drug policy to artemisinin-based combinations in KenyaMalaria Journal, 2007
- Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional studyMalaria Journal, 2007
- Prevalence of poor glycaemic control in diabetics seen in a tertiary medical centreNigerian Postgraduate Medical Journal, 2007
- Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional studyBMJ, 2005
- The process of changing national malaria treatment policy: lessons from country-level studiesHealth Policy and Planning, 2004
- THE MORTALITY CONSEQUENCES OF THE CONTINUED USE OF CHLOROQUINE IN AFRICA: EXPERIENCE IN SIAYA, WESTERN KENYAThe American Journal of Tropical Medicine and Hygiene, 2003
- Increasing antimalarial drug resistance in Uganda and revision of the national drug policyTropical Medicine & International Health, 2002
- Will the Global Fund help roll back malaria in Africa?The Lancet, 2002
- Using evidence to change antimalarial drug policy in KenyaTropical Medicine & International Health, 2000
- Chloroquine‐ and sulfadoxine‐pyrimethamine‐resistant falciparum malaria in vivo– a pilot study in rural ZambiaTropical Medicine & International Health, 2000